MedPath

Questionnaires and Cognitive Assessments Following Mammography

Terminated
Conditions
Health Status Unknown
Interventions
Other: Cognitive Assessment
Other: Questionnaire Administration
Registration Number
NCT03412370
Lead Sponsor
University of Southern California
Brief Summary

This pilot research trial studies how well questionnaires and cognitive assessments work in tracking patient symptoms following mammography. Gathering information over time through questionnaires and cognitive tests about symptoms patients may experience after a mammogram may help doctors understand the cause of these symptoms.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the feasibility of Internet-based cognitive assessments as preliminary data prior to larger clinical trial.

OUTLINE:

Patients complete questionnaires and cognitive assessments over 45-60 minutes within 3 weeks following mammography and at about 3 months in patients for whom biopsy is not required, before biopsy and at about 3 months in patients for whom biopsy is required, and at 4-6 weeks after first chemotherapy infusion in patients receiving chemotherapy.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
6
Inclusion Criteria
  • Mammography Breast Imaging Reporting and Data System (BI-RAD) 4-5; or BI-RAD 1-2
  • Fluent in English
  • Access to Internet
  • Ability to understand and the willingness to sign a written informed consent
Read More
Exclusion Criteria
  • Prior abnormal mammography
  • Prior cancer diagnosis
  • Prior treatment with chemotherapy
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Observational (questionnaires, cognitive assessment)Cognitive AssessmentPatients complete questionnaires and cognitive assessments over 45-60 minutes within 3 weeks following mammography and at about 3 months in patients for whom biopsy is not required, before biopsy and at about 3 months in patients for whom biopsy is required, and at 4-6 weeks after first chemotherapy infusion in patients receiving chemotherapy.
Observational (questionnaires, cognitive assessment)Questionnaire AdministrationPatients complete questionnaires and cognitive assessments over 45-60 minutes within 3 weeks following mammography and at about 3 months in patients for whom biopsy is not required, before biopsy and at about 3 months in patients for whom biopsy is required, and at 4-6 weeks after first chemotherapy infusion in patients receiving chemotherapy.
Primary Outcome Measures
NameTimeMethod
Number of patients invited who agree to participateUp to 2 years

Number of patients invited will be reported.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

USC / Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath